Assessment of ovarian function with anti-Müllerian hormone in systemic lupus erythematosus patients undergoing hematopoietic stem cell transplant

Fertility and Sterility

Volumn 91, Issue 4 SUPPL., 2009, Pages 1529-1532

  Browne, Hyacinth ^a   Armstrong, Alicia ^a   DeCherney, Alan ^a   Babb, Rebecca ^b   Illei, Gabor ^c   Segars, James ^a   Pavletic, Steven ^b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

anti M llerian hormone; ovarian reserve; Stem cell transplant

Indexed keywords

MUELLERIAN INHIBITING FACTOR;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HORMONE BLOOD LEVEL; HUMAN; OVARIAN RESERVE; OVARY FUNCTION; PREGNANCY OUTCOME; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; ANTI-MULLERIAN HORMONE; BIOLOGICAL MARKERS; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MENSTRUATION; OVARY; PILOT PROJECTS; REPRODUCTION; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 63249137057     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.08.123     Document Type: Article

References (14)

1. Burt R., Traynor A., Statkute L., Barr W., Rosa R., Schroeder J., et al. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA 295 (2006) 527-535
2. van Beek R., van den Heuvel-Eibrink M., Laven J., de Jong F., Themmen A., Hakvoort-Cammel F., et al. Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood. J Clin Endocrinol Metab 92 (2007) 3869-3874
3. Ueno S., Kuroda T., MacLaughlin D., Ragin R., Manganaro T., and Donahoe P. Mullerian inhibiting substance in the adult rat ovary during various stages of the estrus cycle. Endocrinology 125 (1989) 1060-1066
4. van Rooij I., Tonkelaar I., Broekmans F., Looman C., Scheffer G., de Jong F., et al. Anti-mullerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause 11 (2004) 601-606
5. Fanchin R., Schonauer L., Righini C., Guibourdenche J., Frydman R., and Taieb J. Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH, and LH on day 3. Hum Reprod 18 (2003) 323-327
6. Seifer D., MacLaughlin D., Christian B., Feng B., and Shelden R. Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril 77 (2002) 468-471
7. Muttukrishna S., McGarrigle H., Wakim R., Khadum I., Ranieri D., and Serhal P. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?. Br J Obstet Gynecol 112 (2005) 1384-1390
8. Ficicioglu C., Kutlu T., Baglam E., and Bakacak Z. Early follicular antimullerian hormone as an indicator of ovarian reserve. Fertil Steril 85 (2006) 592-596
9. Anderson R., Themmen A., Al-Qahtani A., Groome N., and Cameron D. The effects of chemotherapy and long-term gonadotropin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum Reprod 21 (2006) 2583-2592
10. Oktay K., Oktem O., Reh A., and Vahdat L. Measuring the impact of chemotherapy on fertility in women with breast cancer. J Clin Oncol 24 (2006) 4044-4046
11. Armstrong A., Callis K., and Nelson L. Premature menopause in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Nat Clin Pract Endocrinol Metab 3 (2007) 326-327
12. Larsen E., Muller J., Rechnitzer C., Schmiegelow K., and Anderson A. Diminshed ovarian reserve in female childhood cancer survivors with regular menstrual cycles and basal FSH <10 IU/L. Hum Reprod 18 (2003) 417-422
13. Larsen E., Muller J., Schmiegelow K., Rechnitzer C., and Andersen A. Reduced ovarian function in long-term survivors of radiation-and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab 88 (2003) 5307-5314
14. Bath L., Wallace W., Fitzpatrick C., Shaw P., and Anderson R. Depletion of the ovarian reserve in young women following treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound. Hum Reprod 18 (2003) 2368-2374